Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2313402,Anxrr24,Anxiety related response QTL 24,,,aggression-related behavior trait (VT:0015014),tameness/aggressiveness composite score (CMO:0002136),1,49147799,156446783,Rat,n/a,region,qtl 1000,1554320,Bmd1,Bone mineral density QTL 1,12.2,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),1,254393,86904217,Rat,n/a,region,qtl 1000,1578650,Bmd6,Bone mineral density QTL 6,12.2,,femur mineral mass (VT:0010011),total volumetric bone mineral density (CMO:0001728),1,254393,43579402,Rat,n/a,region,qtl 1000,2313090,Bmd69,Bone mineral density QTL 69,4.4,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),1,1,34993530,Rat,n/a,region,qtl 1000,1578651,Bmd7,Bone mineral density QTL 7,14.2,,femur mineral mass (VT:0010011),cortical volumetric bone mineral density (CMO:0001730),1,254393,43579402,Rat,n/a,region,qtl 1000,2313098,Bmd70,Bone mineral density QTL 70,3.6,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313092,Bmd72,Bone mineral density QTL 72,2.5,0.0001,tibia mineral mass (VT:1000283),total volumetric bone mineral density (CMO:0001728),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313062,Bmd73,Bone mineral density QTL 73,3.9,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),1,11314489,83657083,Rat,n/a,region,qtl 1000,1578649,Bmd8,Bone mineral density QTL 8,4.9,,femur mineral mass (VT:0010011),trabecular volumetric bone mineral density (CMO:0001729),1,49578577,94578577,Rat,n/a,region,qtl 1000,724520,Bp145,Blood pressure QTL 145,2.1,0.0024,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,21079305,66079305,Rat,n/a,region,qtl 1000,731169,Bp153,Blood pressure QTL 153,,0.001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,33667777,36129328,Rat,n/a,region,qtl 1000,1300172,Bp172,Blood pressure QTL 172,3.56,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),1,35377508,94364229,Rat,n/a,region,qtl 1000,2316649,Bp344,Blood pressure QTL 344,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,34888392,35680732,Rat,n/a,region,qtl 1000,7421626,Bp360,Blood pressure QTL 360,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,4578693,49578693,Rat,n/a,region,qtl 1000,10059597,Bp377,Blood pressure QTL 377,3.42,0.025,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,35377692,217372257,Rat,n/a,region,qtl 1000,70225,Bp58,Blood pressure QTL 58,3.3,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,34993530,173445086,Rat,n/a,region,qtl 1000,631494,Bp95,Blood pressure QTL 95,40,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,21300822,49454378,Rat,n/a,region,qtl 1000,631495,Bp96,Blood pressure QTL 96,4.52,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,23406428,108057505,Rat,n/a,region,qtl 1000,1578654,Bss10,Bone structure and strength QTL 10,4,,femur morphology trait (VT:0000559),femoral neck cortical cross-sectional area (CMO:0001702),1,49578577,169852184,Rat,n/a,region,qtl 1000,5684998,Bss101,Bone structure and strength QTL 101,3.6,,tibia strength trait (VT:1000284),tibia ultimate force (CMO:0001734),1,16143143,49547474,Rat,n/a,region,qtl 1000,5684999,Bss102,Bone structure and strength QTL 102,5.5,0.00000072,tibia strength trait (VT:1000284),tibia stiffness (CMO:0001735),1,16143143,49547474,Rat,n/a,region,qtl 1000,2313053,Bss51,Bone structure and strength QTL 51,3.8,0.0001,tibia length (VT:0004357),tibia length (CMO:0000450),1,1,34993530,Rat,n/a,region,qtl 1000,2313070,Bss52,Bone structure and strength QTL 52,4.4,0.0001,body length (VT:0001256),body length (CMO:0000013),1,1,34993530,Rat,n/a,region,qtl 1000,2313072,Bss53,Bone structure and strength QTL 53,4.3,0.0001,tibia length (VT:0004357),tibia length (CMO:0000450),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313078,Bss54,Bone structure and strength QTL 54,3.5,0.0001,tibia area (VT:1000281),tibia midshaft cross-sectional area (CMO:0001717),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313059,Bss55,Bone structure and strength QTL 55,3.2,0.0001,tibia size trait (VT:0100001),tibia midshaft cross-sectional area (CMO:0001717),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313099,Bss56,Bone structure and strength QTL 56,2.4,0.0001,tibia size trait (VT:0100001),tibia midshaft endosteal cross-sectional area (CMO:0001716),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313051,Bss57,Bone structure and strength QTL 57,3.7,0.0001,tibia strength trait (VT:1000284),bone polar moment of inertia (CMO:0001558),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313094,Bss58,Bone structure and strength QTL 58,3.7,0.0001,tibia strength trait (VT:1000284),tibia total energy absorbed before break (CMO:0001736),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313075,Bss66,Bone structure and strength QTL 66,3.4,0.0001,tibia length (VT:0004357),tibia length (CMO:0000450),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313065,Bss67,Bone structure and strength QTL 67,3.1,0.0001,tibia area (VT:1000281),tibia total energy absorbed before break (CMO:0001736),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313069,Bss68,Bone structure and strength QTL 68,2.9,0.0001,tibia size trait (VT:0100001),tibia total energy absorbed before break (CMO:0001736),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313077,Bss69,Bone structure and strength QTL 69,3.5,0.0001,tibia strength trait (VT:1000284),bone polar moment of inertia (CMO:0001558),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313097,Bss70,Bone structure and strength QTL 70,3.5,0.0001,tibia strength trait (VT:1000284),tibia total energy absorbed before break (CMO:0001736),1,11314489,83657083,Rat,n/a,region,qtl 1000,4889919,Bss86,Bone structure and strength QTL 86,4.1,,tibia area (VT:1000281),tibia midshaft total cross-sectional area (CMO:0001715),1,53851348,83657083,Rat,n/a,region,qtl 1000,4889929,Bss87,Bone structure and strength QTL 87,6.7,,tibia area (VT:1000281),tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722),1,53851348,83657083,Rat,n/a,region,qtl 1000,1578669,Bss9,Bone structure and strength QTL 9,6.3,,femur morphology trait (VT:0000559),bone trabecular cross-sectional area (CMO:0002311),1,254393,43579402,Rat,n/a,region,qtl 1000,4889962,Bss94,Bone structure and strength QTL 94,3.8,,tibia area (VT:1000281),tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722),1,49547328,83657083,Rat,n/a,region,qtl 1000,1354599,Bw29,Body weight QTL 29,3.46,0.001,body mass (VT:0001259),body weight (CMO:0000012),1,34449112,79449112,Rat,n/a,region,qtl 1000,1357397,Bw41,Body weight QTL 41,4.19,0.0001,body mass (VT:0001259),body weight (CMO:0000012),1,23406428,49547474,Rat,n/a,region,qtl 1000,1357401,Bw43,Body weight QTL 43,3.75,,body mass (VT:0001259),body weight (CMO:0000012),1,23406428,49547474,Rat,n/a,region,qtl 1000,1357400,Bw62,Body weight QTL62,4.05,,inguinal fat pad mass (VT:0010424),inguinal fat pad weight to body weight ratio (CMO:0001253),1,23406428,68406428,Rat,n/a,region,qtl 1000,1354647,Despr8,Despair related QTL 8,,0.0000341,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),1,1,24368159,Rat,n/a,region,qtl 1000,4889451,Eae29,Experimental allergic encephalomyelitis QTL 29,5.51,,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis severity score (CMO:0001419),1,5655772,85706974,Rat,n/a,region,qtl 1000,1358192,Ept13,Estrogen-induced pituitary tumorigenesis QTL 13,3.4,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),1,24297799,78748000,Rat,n/a,region,qtl 1000,1354643,Foco2,Food consumption QTL 2,7.17,0.0001,eating behavior trait (VT:0001431),food intake rate (CMO:0000427),1,34449112,79449112,Rat,n/a,region,qtl 1000,2317755,Glom22,Glomerulus QTL 22,3.8,,urine protein amount (VT:0005160),urine protein level (CMO:0000591),1,11314658,34993348,Rat,n/a,region,qtl 1000,631688,Hcas2,Hepatocarcinoma susceptibility QTL 2,3,0.0001,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),1,5655769,122614963,Rat,n/a,region,qtl 1000,1300167,Hrtrt2,Heart rate QTL 2,4.35,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),1,11314489,75844121,Rat,n/a,region,qtl 1000,1578756,Iddm22,Insulin dependent diabetes mellitus QTL 22,2.7,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),1,50522714,57861469,Rat,n/a,region,qtl 1000,9589820,Insglur3,Insulin/glucose ratio QTL 3,10.75,0.001,blood insulin amount (VT:0001560),calculated plasma insulin level (CMO:0002170),1,35854167,80854167,Rat,n/a,region,qtl 1000,1600360,Mcs16,Mammary carcinoma susceptibility QTL 16,2.4,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),1,1868045,43724576,Rat,n/a,region,qtl 1000,2298546,Neuinf4,Neuroinflammation QTL 4,5.1,,nervous system integrity trait (VT:0010566),spinal cord RT1-B protein level (CMO:0002132),1,1,28468970,Rat,n/a,region,qtl 1000,634314,Niddm44,Non-insulin dependent diabetes mellitus QTL 44,,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),1,49578693,217054291,Rat,n/a,region,qtl 1000,2302038,Pia31,Pristane induced arthritis QTL 31,5.5,0.001,blood autoantibody amount (VT:0003725),serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111),1,13629251,58629251,Rat,n/a,region,qtl 1000,2302059,Pia36,Pristane induced arthritis QTL 36,3.8,0.001,blood immunoglobulin amount (VT:0002460),serum immunoglobulin G1 level (CMO:0002115),1,41907249,86907249,Rat,n/a,region,qtl 1000,738020,Pia8,Pristane induced arthritis QTL 8,4.7,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),1,1,64407321,Rat,n/a,region,qtl 1000,8552900,Pigfal1,Plasma insulin-like growth factor 1 level QTL 1,7.4,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),1,35854167,80854167,Rat,n/a,region,qtl 1000,8552948,Pigfal11,Plasma insulin-like growth factor 1 level QTL 11,4.7,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),1,35854167,80854167,Rat,n/a,region,qtl 1000,1558642,Prcr2,Prostate cancer resistance QTL 2,4.3,,prostate integrity trait (VT:0010571),area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899),1,21812623,44409802,Rat,n/a,region,qtl 1000,634353,Rends2,Renal damage susceptibility QTL 2,,0.05,kidney blood vessel morphology trait (VT:0000530),organ lesion measurement (CMO:0000677),1,20341560,58000154,Rat,n/a,region,qtl 1000,1331785,Rf27,Renal function QTL 27,4.643,,urine sodium amount (VT:0006274),urine sodium level (CMO:0000129),1,31489454,79689689,Rat,n/a,region,qtl 1000,1331778,Rf28,Renal function QTL 28,4.66,,urine potassium amount (VT:0010539),urine potassium excretion rate (CMO:0000761),1,46113461,79689689,Rat,n/a,region,qtl 1000,1331792,Rf29,Renal function QTL 29,4.589,,urine potassium amount (VT:0010539),urine potassium level (CMO:0000128),1,36033165,79689689,Rat,n/a,region,qtl 1000,631508,Sald1,Serum aldosterone level QTL 1,3.7,,blood aldosterone amount (VT:0005346),serum aldosterone level (CMO:0000487),1,12493439,57493439,Rat,n/a,region,qtl 1000,6903308,Scl36,Serum cholesterol QTL 36,2,0.0125,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),1,50522714,94225616,Rat,n/a,region,qtl 1000,1358359,Sradr1,Stress Responsive Adrenal Weight QTL 1,4.74,,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),1,25951907,130917265,Rat,n/a,region,qtl 1000,1331732,Srn4,Serum renin concentration QTL 4,4.467,,renin activity (VT:0005581),plasma renin activity level (CMO:0000116),1,36033165,79689689,Rat,n/a,region,qtl 1000,70179,Xhs2,X-ray hypersensitivity QTL 2,3.2,,intestine integrity trait (VT:0010554),post-insult time to onset of moribundity (CMO:0001896),1,16033078,20130904,Rat,n/a,region,qtl